Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Anti-idiotypic
Reexamination Certificate
2004-04-16
2011-10-11
Bristol, Lynn (Department: 1643)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Anti-idiotypic
C435S069600, C436S547000, C530S387200, C530S387300
Reexamination Certificate
active
08034338
ABSTRACT:
The invention refers to an immunogenic recombinant antibody designed for immunization of primates comprising at least a part of a murine IgG2a subtype amino acid sequence and a mammalian glycosylation.
REFERENCES:
patent: 5977315 (1999-11-01), Chatterjee et al.
patent: 2005/0163768 (2005-07-01), Eckert et al.
patent: 2360382 (2000-07-01), None
patent: 2391927 (2001-05-01), None
patent: 10059930 (2002-05-01), None
patent: 0285059 (1988-10-01), None
patent: 0759442 (1997-02-01), None
patent: WO-9324647 (1993-12-01), None
patent: 97/40140 (1997-10-01), None
patent: WO-0041722 (2000-07-01), None
patent: 01/21796 (2001-03-01), None
patent: WO-0135989 (2001-05-01), None
patent: WO 03/074679 (2003-09-01), None
patent: WO-03097663 (2003-11-01), None
Campbell et al, Biology, 5th ed. p. 856, 1999.
Fundamental Immunology 242 (William E. Paul, M.D. ed., 3d ed. 1993).
MacCallum et al. (J. Mol. Biol. (1996) 262:732-745).
Pascalis et al. The Journal of Immunology (2002) 169, 3076-3084.
Casset et al. (2003) BBRC 307, 198-205.
Vajdos et al. (2002) J. Mol. Biol. 320, 415-428.
Holm et al (2007) Mol. Immunol. 44: 1075-1084.
Chen et al. J. Mol. Bio. (1999) 293, 865-881.
Wu et al. J. Mol. Biol. (1999) 294, 151-162.
Smith-Gill et al. (J. Immunol. 139:4135-4144 (1987)).
Kumar et al. (J. Biol. Chem. 275:35129-35136 (2000)).
Song et al. (Biochem Biophys Res Comm 268:390-394 (2000)).
ATCC search output for HB 9347 hybridoma.
ATCC search output for HB 9324 hybridoma.
Wright et al (Springer Semin Immunopathology ,15 :259-273 (1993)).
Delente (Trends in Biotechnology 3, letters to editor, No. 9, (1985)).
Olden et al (Biochem et Biophys Acta 650:209-232 (1982)).
Salfeld (Nature Biotech. 25(12): 1369-1372 (2007)).
Lund et al. (The Journal of Immunology 1996, 157:4963-4969).
ATCC website search output for “HB-9324” (p. 1, Feb. 2, 2009).
ATCC website search output for “HB-9347” (p. 1, Feb. 2, 2009).
Debe et al. (U.S. Appl. No. 09/791,537, filed Feb. 2, 2001).
Sequence search alignment for SEQ ID No. 3 (p. 1, Sep. 12, 2009).
Steinitz, M. et al., “Human monoclonal anti-idiotypic antibodies. I. Establishment of immortalized cell lines from a tumor patient treated with mouse monoclonal antibodies”, Journal of Immunology, Nov. 15, 1988, vol. 141, No. 10, pp. 3516-3522.
Fagerberg, J. et al., “Humoral anti-idiotypic and anti-anti-idiotypic immune response in cancer patients treated with monoclonal antibody 17-1A”, Cancer Immunology, Immunotherapy: CII, 1996, vol. 42, No. 2, pp. 81-87 (Abstract).
Brumeanu, T.-D. et al., “Engineering of doubly antigenized immunoglobulins expressing T and B viral epitopes,” Immunotechnology, 1996, vol. 2, pp. 85-95.
Saleh, M. et al., “Generation of a human anti-idiotypic antibody that mimics the GD2 antigen” Journal of Immunology, vol. 151, No. 6, Sep. 15, 1993, pp. 3390-3398.
Waxenecker, G. et al., “Qualitative and quantitative dissection of the immune response to the cancer vaccine candidates IGN101 and IGN301” Proceedings of the Annual Meeting of the American Association for Cancer Research, vol. 43, Mar. 2002, pp. 560.
Wallick, C.S. et al., “Glycosylation of a VH residue of a monoclonal antibody against alpha (1-6) dextran increases its affinity for antigen” Journal of Experimental Medicine, vol. 168, Sep. 1988, pp. 1099-1109.
Himmler Gottfried
Loibner Hans
Putz Thomas
Schuster Manfred
Waxenecker Günter
Birch & Stewart Kolasch & Birch, LLP
Bristol Lynn
Igeneon Krebs-Immuntherapie Forschungs-Und Entwicklungs-AG
LandOfFree
Immunogenic recombinant antibody does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunogenic recombinant antibody, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunogenic recombinant antibody will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4275031